Skip to content

Gay men are better at predicting when they won’t have sex than when they will

British HIV cure survey: most respondents would be prepared to take some health risk to help find a cure for HIV

What are the barriers that could stop HIV treatment becoming HIV prevention?

Misunderstanding of questions regarding anal sex in microbicide HIV prevention trial

PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds

Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation

David Margolis presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Raltegravir has the edge over two protease inhibitors in three-drug comparison study

Life expectancy now considerably exceeds the average in some people with HIV in the US